Torrent Pharmaceuticals Ltd · NSE:TORNTPHARM
Torrent Pharmaceuticals — Merger or Acquisition (September 2022)
14 slides from Torrent Pharmaceuticals's merger presentation, Sep 27, 2022
Slide 1: Cover letter to stock exchanges on Curatio acquisition presentation
27th September, 2022 The Dy. General Manager (Listing Dept.) The Manager – Listing Dept., BSE Limited, National Stock Exchange of India Ltd., Corporate Relationship Dept., Exchange Plaza, 5th Floor, 1st Floor, New Trading Ring, Plot No. C/1, G. Block, P. J. Towers, Dalal Street, Fort, Bandra - Kurla
Slide 2: Building Leadership in a High Growth Therapy Area
Building Leadership in a High Growth Therapy Area 27th September 2022 1
Slide 3: Curatio At A Glance
Curatio At A Glance Key Brands Brands 17+ 95% ~Rs 224* Cr Year of operation Dermatology Sales FY’22 Sales 13 50+ ~Rs 275 Cr Brands leader in the Total Brands FY23E Sales covered market ~600 MRs 900+ Online sales channel Sales Force Distributors * 222 cr India Business
Slide 4: Acquisition Positions Torrent as Second largest player in Cosmetic Dermatology
Acquisition Positions Torrent as Second largest player in Cosmetic Dermatology Torrent pharma to acquire 84% contribution from 100% of Curatio India Pvt Ltd. Portfolio of 50+ brands in Cosmetic dermatology; non having operations in India, Dermatology therapy regulated market Nepal, Srilanka & Philip
Slide 5: Growth Opportunity: Derma is a High Growth Therapy Area
Growth Opportunity: Derma is a High Growth Therapy Area Sales Therapy 222 Cr 95% 171 Cr 5% 131 Cr Derma Rest 2019-20 2021-22 H1 Cosmo Derma Medical Derma • As per FY’22 Curatio has registered sales of 222 Cr with 25% Gr 84% 68% • Derma is the key therapy for Curatio 32% contributing 95% in it’s over
Slide 6: Tedibar (Rs. 76 cr sales FY22, YTD August growth 15%)
Tedibar (Rs. 76 cr sales FY22, YTD August growth 15%) <15Y Age 670 L Group Atopic Dermatitis 120 L Incidence Existing Market Condition addressed 25 L Penetration • Dryness and irritation associated with atopic dermatitis • Maintains the pH balance of 5.5 which can get elevated to as high as 6.5 in a
Slide 7: Growth Opportunity: Cosmetic Dermatology is the Key Driver of Derma Growth
Growth Opportunity: Cosmetic Dermatology is the Key Driver of Derma Growth IPM Derma CAGR : 10% CAGR : 13% GP Specialist Dermat GP Specialist Dermat 174k Cr 11.5K Cr 3% 39% 30% 40% 65K Cr 3.3K Cr 58% 30% 2012 2022 2012 2022 Cosmetic Dermatology • CAGR of cosmetic dermatology is 1.6 times than IPM CA
Slide 8: Overview: Curatio Brands can Expand the Covered Market
Overview: Curatio Brands can Expand the Covered Market Torrent Curatio (India)* Torrent + Curatio 4286Cr 222 Cr 4508 Cr § Curatio India has reported sales of 222 Cr in FY22. FY23 E growth is 25% § Top 10 brands contributing 74% of the total sales § Top 3 brands contribute more than 50% of the total
Slide 9: Top 5 brands contribute ~60% to the portfolio
Top 5 brands contribute ~60% to the portfolio Tedibar Atogla Permite/Perlice 32 17 95 27 14 % % 76 % 20 21 25 21-22 22-23 E 21-22 22-23 E 21-22 22-23 E Spoo Clinmiskin Top 5 Brands 10 14 167 8 % 19 137 % 22 % 11 13 21-22 22-23 E 21-22 22-23 E 21-22 22-23 E 21-22: Internal Sales; 22-23 E: Estimated s
Slide 10: Key Brands of Curatio part of high growth market with high market share
Key Brands of Curatio part of high growth market with high market share >10% Mkt CAGR% 11% 52% <10% MS% >10% MS% <10% Mkt CAGR% 22% 15% % contribution to Sales
Slide 11: Top Brands on A High Growth Path
Top Brands on A High Growth Path Revenue Cont.% FY Portfolio Key Products 3 YR CAGR 22 Tedibar : Low Ph bathing bar for Atopic Dermatitis Pedia Products ~60% Atogla Lotion & Cream : Emollients for Atopic Dermatitis 17% Spoo : Rx Driven shampoo for cradle cap Tracnil : Therapy resistant acne, excessi
Slide 12: Torrent enters into the Top league in Dermatology
Torrent enters into the Top league in Dermatology RANK CORPORATE Leadership DERMA 1 GSK • Torrent will be ranked 10th in Derma therapy 2 GLENMARK • Amongst top 5 Rx players amongst Dermatologist 3 SUN* 4 HEGDE & HEGDE Leveraging Curatio’s equity 5 ABBOTT* 6 DR. REDDYS • Concept selling through stron
Slide 13: Enhances Torrent's presence in high growth high value TA's of the market
Enhances Torrent’s presence in high growth high value TA’s of the market Torrent + Torrent Therapy Rank (Val) Therapy Torrent Curatio Strength --- IPM 8 7 √√√ 1 CARDIAC 2 2 √√√√ 3 GI 4 4 √√√√ 9 CNS 4 4 √√√√ 5 VMN 4 4 √√√√ 4 AD (wo Ins) 9 9 √√√ 7 PAIN 8 8 √√√ 8 DERMA 21 10 √√√ 10 GYNAE 17 17 √√ 2 A.I
Slide 14: Thank You
Thank You PHARMA
Torrent Pharmaceuticals — Merger or Acquisition (September 2022) on 6ix